(Q39824364)

14 September 2017

1 reference

title

13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer (English)

1 reference

14 September 2017

1 reference

3

Alberts DS

1 reference

PubMed ID

3893773

14 September 2017

Frank L. Meyskens, Jr.

series ordinal

1

object named as

Meyskens FL Jr

1 reference

14 September 2017

Goodman GE

2

1 reference

PubMed ID

3893773

14 September 2017

language of work or name

1 reference

1 January 1985

1 reference

Critical Reviews in Oncology Hematology

14 September 2017

1 reference

14 September 2017

3

1 reference

14 September 2017

1

1 reference

14 September 2017

75-101

1 reference

Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Relationships between structure and activity of retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Determination of 13-cis-retinoic acid and its major metabolite, 4-oxo-13-cis-retinoic acid, in human blood by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoid-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

The plasma transport and metabolism of retinoic acid in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Phase I trial of retinol in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Chronic vitamin A intoxication in adults. Hepatic, neurologic and dermatologic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

General clinical toxicology of oral retinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

The intestinal absorption and metabolism of vitamin A and beta-carotene in man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Pharmacokinetics of isotretinoin following a single oral dose.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Determination of retinoic acid (13-cis- and all-trans-) and aromatic retinoic acid analogs possessing anti-tumor activity, in biological fluids by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Metabolism of all-trans-retinoic acid in hamster liver microsomes: oxidation of 4-hydroxy- to 4-keto-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Metabolic studies on retinoic acid in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Metabolism of Vitamin A and the Determination of Vitamin A Status

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isolation and identification of three major metabolites of retinoic acid from rat feces

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isolation and identification of three urinary metabolites of retinoic acid in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isolation and identification of 5, 6-epoxyretinoic acid: a biologically active metabolite of retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

RETINOYL BETA-GLUCURONIC ACID: A MAJOR METABOLITE OF VITAMIN A IN RAT BILE

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

The identification of metabolites of retinal and retinoic acid in rat bile

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Dose-dependent kinetics of all-trans-retinoic acid in rats. Plasma levels and excretion into bile, urine, and faeces

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Pharmacokinetics of isotretinoin during repetitive dosing to patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Chemoprevention of Cancer with Retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoids, cancer, and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Teratogenicity of isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Comparative effects of all-trans and 13-cis retinoic acid administration on serum and liver lipids in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isotretinoin and serum lipids.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isotretinoin and serum lipids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Hypercalcemia and skeletal effects in chronic hypervitaminosis A.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Comparative subchronic toxicity of all-trans- and 13-cis-retinoic acid in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoid hyperostosis. Skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for refractory ichthyosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoids, urinary bladder carcinogenesis, and chemoprevention: a review and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Modulation of abnormal growth by retinoids: a clinical perspective of the biological phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Binding of retinoids to human breast cancer cell lines and their effects on cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

The induction of differentiation in teratocarcinoma stem cells by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Histological changes during regression induced by retinoic acid in a transplantable rat chondrosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Mediation of retinoic acid-induced growth and anti-tumour activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Differential binding to soluble nuclear receptors and effects on cell viability of retinol and retinoic acid in cultured retinoblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Effect of 13-cis-retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor colony formation in soft agar

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Use of a human tumor cloning system to screen retinoids for antineoplastic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Effect of retinoids on oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Treatment of keratoacanthomas with oral 13-cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Phase II trial of 13-cis-retinoic acid in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoic acid enhances growth of human early erythroid progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Effects of retinoic acid on the immune system: Stimulation of T killer cell induction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Isotretinoin in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Chemotherapy of psoriasis and other skin disorders with oral retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Evidence for the appearance of non-specific suppressor cells in the blood after local radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Sample size nomograms for interpreting negative clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

The thymosins—preclinical and clinical studies with fraction V and alpha-i

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980040-8

7 January 2021

10.1016/S1040-8428(85)80040-8

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

3893773